Analystreport

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $75.00 price target on the s...

Taro Pharmaceutical Industries Ltd. Ordinary Shares  (TARO) 
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm Check Earnings Report